CTNNB1 and neoplasm: There were significant tumor burden reductions across a wide LNP-CTNNB1 dose range (3mg/kg, 1mg/kg, 0.3mg/kg, and 0.1mg/kg), as evident by gross visualization and reduced LW/BW ratio (Figure S2b–f, Figure 1c–g).